Status:
TERMINATED
HCV, HBV, HIV Testing During Consultation With Anesthesiologist
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Gilead Sciences
Conditions:
HCV
HBV
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of the study is to assess the feasibility of HCV, HBV, HIV testing (according to the national guidelines) during consultation with Anesthesiologist before a planned surgery in Lariboisiere Hos...
Detailed Description
The aim of the study is to assess the feasibility of HCV, HBV, HIV testing during consultation with Anesthesiologist before a planned surgery in Lariboisiere Hospital, Paris, France. The national gui...
Eligibility Criteria
Inclusion
- patient ≥ 18 years-old
- planned surgery in Lariboisiere Hospital, Paris, France
- able to give written informed consent for testing
- proposed to be tested for HIV and HCV if no previous testing found in the medical record
- proposed to be tested for HBV if the patient belong to a high-risk group: high prevalence area (Asia, sub-Saharan Africa, French Indies, East and South Europe, North-Africa, Middle-East, India, Pakistan, South-America), IVDU, prisoners, unprotected sexual intercourses.
Exclusion
- patient \< 18 years-old
- emergency surgery
- unable to give written informed consent for testing: psychiatric diseases, neurologic diseases, …
- a previous testing for HIV and HCV found in the medical record and no obvious risk factor after previous testing
- the patient does not belong to a high-risk group for HBV
Key Trial Info
Start Date :
August 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 27 2021
Estimated Enrollment :
363 Patients enrolled
Trial Details
Trial ID
NCT04286347
Start Date
August 5 2021
End Date
October 27 2021
Last Update
December 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lariboisière
Paris, France, 75475